Global Glycomics & Glycobiology Market Growth (Status and Outlook) 2023-2029

Global Glycomics & Glycobiology Market Growth (Status and Outlook) 2023-2029

Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).

Glycobiology is fast emerging as a primary field of interest for biomolecular and biomedical research around the globe. Once considered merely supporting structures, the sugars have now been widely recognized to be a vital component in running the complex machinery of life itself.
LPI (LP Information)' newest research report, the “Glycomics & Glycobiology Industry Forecast” looks at past sales and reviews total world Glycomics & Glycobiology sales in 2022, providing a comprehensive analysis by region and market sector of projected Glycomics & Glycobiology sales for 2023 through 2029. With Glycomics & Glycobiology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glycomics & Glycobiology industry.
This Insight Report provides a comprehensive analysis of the global Glycomics & Glycobiology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glycomics & Glycobiology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Glycomics & Glycobiology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glycomics & Glycobiology and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glycomics & Glycobiology.
The global Glycomics & Glycobiology market size is projected to grow from US$ 1118.1 million in 2022 to US$ 2461 million in 2029; it is expected to grow at a CAGR of 11.9% from 2023 to 2029.
Global Glycomics/Glycobiology key players include ThermoFisher Scientific, Danaher, Shimadzu Corporation, ProZyme, etc. Global top four manufacturers hold a share over 15%.
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
In terms of product, Instruments is the largest segment, with a share about 33%. And in terms of application, the largest application is Drug Discovery & Development, followed by Diagnostics, etc.
This report presents a comprehensive overview, market shares, and growth opportunities of Glycomics & Glycobiology market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Instruments
Enzymes
Reagents
Kits
Segmentation by application
Drug Discovery & Development
Diagnostics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
ThermoFisher Scientific
Danaher
Shimadzu Corporation
ProZyme
Takara Bio, Inc.
Agilent Technologies
Bruker
Promega
Waters Corporation
R&D Systems
New England Biolabs
Merck KGaA

Please note: The report will take approximately 2 business days to prepare and deliver.